Deal Dive: Cutting through the noise in a category clouded by catastrophic failure


Share post:

Building a startup is hard enough but growing one in a category marred with Theranos-sized stigma is a new level of challenge. Vital Bio seems up for the test.

The Toronto-based startup is building a machine, VitalOne, that can perform more than 50 blood tests — covering nearly all of those considered routine — and get patient results back in 20 minutes, not multiple days. Co-founder and CEO Vasu Nadella said that he got interested in the space because he and his co-founders have watched family members deal with chronic illness and know that being able to get quick diagnostic results is crucial for treatment.

Plus, Nadella wanted to know why companies couldn’t seem to get the solution to this problem right. While Theranos failed for a variety of reasons, the other companies trying to build these quicker blood diagnostic tools had yet to ship products. He thought maybe he could crack the code.

The startup launched in 2019 and built quietly until it debuted its device at the American Association of Clinical Chemistry’s annual meeting — the industry’s “Super Bowl” — last Monday. Vital Bio also announced that it had raised $48 million in venture funding from Labcorp, Inovia Capital, Lachy Groom and Sam Altman, among others.

Nadella said the company has focused on making sure that its device produces accurate results and that when it does drift, they know how to prevent it from impacting the final diagnosis. He said the company waited to start talking about what it was up to until it felt it had enough to back up its claims.

Source link

Lisa Holden
Lisa Holden
Lisa Holden is a news writer for LinkDaddy News. She writes health, sport, tech, and more. Some of her favorite topics include the latest trends in fitness and wellness, the best ways to use technology to improve your life, and the latest developments in medical research.

Recent posts

Related articles

Adapting to a world with higher interest rates — a guide for startups

Mohit Agarwal Contributor Mohit Agarwal is a leader at a global management consulting firm based in New York, where...

Ten Key Labs wants to simplify managing equity for startups

Amar Varma, a three-time entrepreneur and VC, experienced firsthand the challenge of dealing with administering equity stakes...

HCVC is back with a new $75 million deep tech fund

Paris-based VC firm HCVC just announced the final closing of its second fund simply called “Fund II”....

Cloaked manages your logins with proxy emails, phone numbers and a built-in password manager

Boston-based privacy and security startup Cloaked, launched its apps today to let users create unique proxy emails,...

Stitch raises $25M Series A extension led by Ribbit Capital, increasing the round’s total to $46M

Open banking, in which traditional banks release their data via application programming interfaces (APIs) to enable the...

Unitary AI picks up $15M for its multimodal approach to video content moderation

Content moderation continues to be a contentious topic in the world of online media. New regulations and...

Elon Musk is being sued for defamation after falsely claiming a man was a neo-Nazi on X

Elon Musk has been on something of a suing spree lately, but on Monday Twitter’s new owner...

Tesla Autopilot arbitration win could set legal benchmark in auto industry

In a victory for Tesla, a California federal judge ruled over the weekend that a group of...